Ardx marketwatch

Interactive Chart for Ardelyx, Inc. (ARDX), analyze all the data with a huge range of indicators.

Ardx marketwatch. Discover real-time Ardelyx, Inc. Common Stock (ARDX) stock prices, quotes, historical data, news, and Insights for informed trading and investment decisions. Stay ahead with Nasdaq.

This reflects a positive earnings surprise of 15.38%. Look out for ARDX's next earnings release expected on August 07, 2024. For the next earning release, we expect the company to report earnings ...

ARDX Earnings Date and Information. Ardelyx last issued its quarterly earnings data on May 2nd, 2024. The biopharmaceutical company reported ($0.11) earnings per share for the quarter, topping the consensus estimate of ($0.13) by $0.02. The business earned $46 million during the quarter, compared to analysts' expectations of $36.40 million.Ardelyx Inc. company facts, information and financial ratios from MarketWatch.Discover real-time Ardelyx, Inc. Common Stock (ARDX) stock prices, quotes, historical data, news, and Insights for informed trading and investment decisions. Stay ahead with Nasdaq.Find out the latest stock news, prices and quotes for Advanced Micro Devices Inc. (AMD), a leading semiconductor company, on MarketWatch.ARDX. Value-focused investors are always on the hunt for stocks that are priced below their intrinsic value. One such stock that merits attention is Ardelyx Inc ( NASDAQ:ARDX ). The stock, which ...

Ardelyx Inc. company facts, information and financial ratios from MarketWatch.ARDX | Complete Ardelyx Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.According to the issued ratings of 9 analysts in the last year, the consensus rating for Ardelyx stock is Buy based on the current 8 buy ratings and 1 strong buy rating for ARDX. The average twelve-month price prediction for Ardelyx is $12.81 with a high price target of $15.00 and a low price target of $8.50. Learn more on ARDX's analyst rating ...Bank of Nova Scotia. $63.30. -0.38. -0.60%. SPTSE | A complete S&P/TSX 60 Index index overview by MarketWatch. View stock market news, stock market data and trading information.ARDX | Complete Ardelyx Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.After-Hours Trades. Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary and as ...

AMP | Complete Ameriprise Financial Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. ... ARDX $8.04. 18.41% 1.25. Access Premium Tools ...ARDX Earnings Date and Information. Ardelyx last issued its quarterly earnings data on May 2nd, 2024. The biopharmaceutical company reported ($0.11) earnings per share for the quarter, topping the consensus estimate of ($0.13) by $0.02. The business earned $46 million during the quarter, compared to analysts' expectations of $36.40 million.After-Hours Trades. Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary and as ...Read more on 'MarketWatch' Indices Commodities Currencies StocksStocktwits provides real-time stock, crypto & international market data to keep you up-to-date. Find top news headlines, discover your next trade idea, share & gain insights from traders and investors from around the world, build a watchlist, buy US stocks, & create and manage your portfolio.

Amc theater michigan city.

Ardelyx Inc. Quarterly balance sheet by MarketWatch. View all ARDX assets, cash, debt, liabilities, shareholder equity and investments. Ardelyx Inc. company facts, information and financial ratios from MarketWatch. Ardelyx Inc. analyst ratings, historical stock prices, earnings estimates & actuals. ARDX updated stock price target summary.0.11%. $878.93M. ADC | Complete Agree Realty Corp. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.04:12 Benchmark Treasury yields hug five-week lows ahead of CPI data MarketWatch; 03:00 The Global Trade War Just Got Worse. It’s Bad for China and Everyone Else. Barron's Online; 02:30 Grayscale’s Bitcoin Fund Has Hefty Fees. Why You Might Be Stuck. Barron's Online; 02:00 How to Invest in Options as You Wait for the Fed’s Next Move ...

Shares of Ardelyx Inc. ARDX, +1.74% soared 27.2% on massive volume in midday trading Wednesday, and have now nearly doubled in two days since the company announced plans to launch its treatment ...Their ARDX share price targets range from $8.50 to $15.00. On average, they expect the company's stock price to reach $12.81 in the next twelve months. This suggests a possible upside of 59.0% from the stock's current price. View analysts price targets for ARDX or view top-rated stocks among Wall Street analysts.Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools. Finviz Elite. 09:57AM. Wedbush Adjusts Ardelyx's Price Target to $15 From $14, Keeps Outperform Rating. (MT Newswires) 07:31AM. Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday. (InvestorPlace)Complete Ardelyx Inc. stock information by Barron's. View real-time ARDX stock price and news, along with industry-best analysis.View the latest Ardelyx Inc. (ARDX) stock price, news, historical charts, analyst ratings and financial information from WSJ.10:28p Bill Hwang’s hedge fund was ’a house of cards’ based on lies, prosecutors say as trial begins ; 9:37p Explosives used to demolish collapsed Baltimore bridge to help free cargo ship ...Nov 17, 2022 · Shares of Ardelyx Inc. rocketed 75.4% on heavy volume toward a 16-month high in premarket trading Thursday, after an advisory panel of the U.S. Food and Drug Administration voted that benefits of ... MarketWatch · 2024/04/12 16:50 · 花旗集團2024年第一季度業績和關鍵指標. moomoo資訊 · 2024/04/12 05:00 · 橡膠手套行業最黑暗的時刻已經過去了嗎?分析師的見解. 專欄 ...

Complete Ardelyx Inc. stock information by Barron's. View real-time ARDX stock price and news, along with industry-best analysis.

Dec 2, 2019 ... 02, 2019 1:18 AM ETAMRX, AQST, ARDX, AX ... Aquestive Therapeutics (AQST). Nov-25-19 08:56AM, Aquestive shares jump on FDA approval MarketWatch + ...ARDX is trading at a 23% premium. Price. $7.74. May 10, 2024. Fair Value. $9.82. May 10, 2024. Uncertainty. Very High. 1-Star Price. $67.47. 5-Star Price.ARDS | Complete Aridis Pharmaceuticals Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.ARDX. -4.95%. Shares in Ardelyx Inc. plummeted more than 70% in after-hours trading Monday, following the biopharmaceutical company's announcement that the Food and Drug Administration appears ...How investing really works: The basicsRead more on 'MarketWatch' Indices Commodities Currencies Stocks0.11%. $878.93M. ADC | Complete Agree Realty Corp. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.Mesa T Ranch operates over 32,000 acres located in Texas and Oklahoma. The ranch is family owned and operated. The Thorpe's run a cow/calf operation as well as stockers and quarter horses.....a good horse is important in the everyday workings of the ranch. The Mesa T Ranch is currently running two stallions: Leo Blue Hancock and MT Rowdy Rip ...2015. $0.39. 2014. $0.68. XME | A complete SPDR S&P Metals & Mining ETF exchange traded fund overview by MarketWatch. View the latest ETF prices and news for better ETF investing.

Administrative civil or criminal sanctions cui.

Ventura electricity outage.

ARDX - Ardelyx Inc. Chart, Quote and financial news from the leading provider and award-winning BigCharts.com. Ardelyx Inc. Annual cash flow by MarketWatch. View ARDX net cash flow, operating cash flow, operating expenses and cash dividends. Ardelyx Inc. company facts, information and financial ratios from MarketWatch.Download Ardelyx Inc. stock data: historical ARDX stock prices from MarketWatch.ARDX | Complete Ardelyx Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.ARDX. -4.95%. Shares in Ardelyx Inc. plummeted more than 70% in after-hours trading Monday, following the biopharmaceutical company's announcement that the Food and Drug Administration appears ...ARDS | Complete Aridis Pharmaceuticals Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.Ardelyx Inc. shares ARDX, +3.38% gained 6% premarket on Monday after the company announced that its partner Kyowa Kirin Co. Ltd. received Japanese regulatory approval for tenapanor for patients ...Shares of Ardelyx (ARDX Quick Quote ARDX - Free Report) have gained 6.3% over the past four weeks to close the last trading session at $9.27, but there could still be a solid upside left in the ...Ardelyx Inc. company facts, information and financial ratios from MarketWatch. ….

ARDX | Complete Ardelyx Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.How investing really works: The basicsRead more on 'MarketWatch' Indices Commodities Currencies StocksNXMH | Complete Next Meats Holdings Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. Ardelyx Inc. Annual balance sheet by MarketWatch. View all ARDX assets, cash, debt, liabilities, shareholder equity and investments. Ardelyx Inc. company facts, information and financial ratios from MarketWatch. Ardelyx Inc. company facts, information and financial ratios from MarketWatch.Ardelyx Inc. Quarterly stock financials by MarketWatch. View the latest ARDX financial statements, income statements and financial ratios.Ardelyx Inc. SEC filings breakout by MarketWatch. View the ARDX U.S. Securities and Exchange Commission reporting information.About ARDX. Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor for the treatment of patients with irritable bowel syndrome with constipation.Think beyond the usual household AI names and look into the future, says Goldman Sachs, which offers a list of long-term plays. Ardx marketwatch, [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1]